Pages that link to "Q40839751"

The following pages link to Cisplatin induces fas expression in esophageal cancer cell lines and enhanced cytotoxicity in combination with LAK cells (Q40839751):

Displaying 17 items.

• Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses (Q24604495) (← links)
• From bench to bedside: immunotherapy for prostate cancer (Q26864390) (← links)
• Up-regulation of Fas reverses cisplatin resistance of human small cell lung cancer cells (Q33878705) (← links)
• p38δ MAPK phenotype: an indicator of chemotherapeutic response in oesophageal squamous cell carcinoma (Q34570398) (← links)
• Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. (Q35781889) (← links)
• The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors (Q35975387) (← links)
• Combining Vaccines with Conventional Therapies for Cancer (Q36082331) (← links)
• Enhancing efficacy of therapeutic vaccinations by combination with other modalities (Q36113943) (← links)
• Attenuated mutant strain of Salmonella Typhimurium lacking the ZnuABC transporter contrasts tumor growth promoting anti-cancer immune response. (Q36232119) (← links)
• Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer (Q36254081) (← links)
• Poxviral vectors for cancer immunotherapy (Q36350388) (← links)
• ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells (Q36798320) (← links)
• Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. (Q36874767) (← links)
• Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts (Q37109176) (← links)
• {2-[(3-Carboxy-1-oxopropyl) amino]-2-deoxy-D-Glucose} suppresses proliferation and induces apoptosis in the human esophageal cancer cell line (Q39696714) (← links)
• Different Mechanisms of Resistance to Lymphokine-activated Killer (LAK) Cells in Leukemic Cell Sublines Selected by Etoposide or by LAK Cells. (Q40835352) (← links)
• Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer (Q44583968) (← links)